Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Pathog ; 14(11): e1007436, 2018 11.
Article in English | MEDLINE | ID: mdl-30496294

ABSTRACT

Invasion of human erythrocytes is essential for Plasmodium falciparum parasite survival and pathogenesis, and is also a complex phenotype. While some later steps in invasion appear to be invariant and essential, the earlier steps of recognition are controlled by a series of redundant, and only partially understood, receptor-ligand interactions. Reverse genetic analysis of laboratory adapted strains has identified multiple genes that when deleted can alter invasion, but how the relative contributions of each gene translate to the phenotypes of clinical isolates is far from clear. We used a forward genetic approach to identify genes responsible for variable erythrocyte invasion by phenotyping the parents and progeny of previously generated experimental genetic crosses. Linkage analysis using whole genome sequencing data revealed a single major locus was responsible for the majority of phenotypic variation in two invasion pathways. This locus contained the PfRh2a and PfRh2b genes, members of one of the major invasion ligand gene families, but not widely thought to play such a prominent role in specifying invasion phenotypes. Variation in invasion pathways was linked to significant differences in PfRh2a and PfRh2b expression between parasite lines, and their role in specifying alternative invasion was confirmed by CRISPR-Cas9-mediated genome editing. Expansion of the analysis to a large set of clinical P. falciparum isolates revealed common deletions, suggesting that variation at this locus is a major cause of invasion phenotypic variation in the endemic setting. This work has implications for blood-stage vaccine development and will help inform the design and location of future large-scale studies of invasion in clinical isolates.


Subject(s)
Erythrocytes/parasitology , Plasmodium falciparum/genetics , Protozoan Proteins/genetics , Animals , Antibodies, Protozoan/immunology , Carrier Proteins/metabolism , Genetic Testing/methods , Humans , Ligands , Phenotype , Protozoan Proteins/metabolism , Reticulocytes/metabolism
2.
Genome Res ; 26(9): 1288-99, 2016 09.
Article in English | MEDLINE | ID: mdl-27531718

ABSTRACT

The malaria parasite Plasmodium falciparum has a great capacity for evolutionary adaptation to evade host immunity and develop drug resistance. Current understanding of parasite evolution is impeded by the fact that a large fraction of the genome is either highly repetitive or highly variable and thus difficult to analyze using short-read sequencing technologies. Here, we describe a resource of deep sequencing data on parents and progeny from genetic crosses, which has enabled us to perform the first genome-wide, integrated analysis of SNP, indel and complex polymorphisms, using Mendelian error rates as an indicator of genotypic accuracy. These data reveal that indels are exceptionally abundant, being more common than SNPs and thus the dominant mode of polymorphism within the core genome. We use the high density of SNP and indel markers to analyze patterns of meiotic recombination, confirming a high rate of crossover events and providing the first estimates for the rate of non-crossover events and the length of conversion tracts. We observe several instances of meiotic recombination within copy number variants associated with drug resistance, demonstrating a mechanism whereby fitness costs associated with resistance mutations could be compensated and greater phenotypic plasticity could be acquired.


Subject(s)
Drug Resistance/genetics , Genetic Variation , Malaria, Falciparum/genetics , Plasmodium falciparum/genetics , Chromosome Mapping , DNA Copy Number Variations/genetics , Genome, Protozoan/genetics , High-Throughput Nucleotide Sequencing , Humans , INDEL Mutation , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Meiosis/genetics , Plasmodium falciparum/drug effects , Plasmodium falciparum/pathogenicity , Polymorphism, Single Nucleotide , Recombination, Genetic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...